Physicians’ preferences for bone metastases treatments in France, Germany and the United Kingdom View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-12

AUTHORS

Yi Qian, Jorge Arellano, Francesca Gatta, Guy Hechmati, A. Brett Hauber, Ateesha F. Mohamed, Amit Bahl, Roger von Moos, Jean-Jacques Body

ABSTRACT

BACKGROUND: Several bone-targeted agents (BTAs) are available for preventing skeletal-related events (SREs), but they vary in terms of efficacy, safety and mode of administration. This study assessed data on European physicians' treatment preferences for preventing SREs in patients with bone metastases from solid tumours. METHODS: Physicians completed a web-based discrete-choice experiment survey of 10 choices between pairs of profiles of hypothetical BTAs for a putative patient. Each profile included five attributes within a pre-defined range (primarily based on existing BTAs' prescribing information): time (months) until the first SRE; time (months) until worsening of pain; annual risk of osteonecrosis of the jaw (ONJ); annual risk of renal impairment; and mode of administration. Choice questions were developed using an experimental design with known statistical properties. A separate main-effects random parameters logit model was estimated for each country and provided the relative preference for the treatment attributes in the study. RESULTS: A total of 191 physicians in France, 192 physicians in Germany, and 197 physicians in the United Kingdom completed the survey. In France and the United Kingdom, time until the first SRE and risk of renal impairment were the most important attributes; in Germany, time until the first SRE and delay in worsening of pain were the most important. In all countries, a 120-min infusion every 4 weeks was the least preferred mode of administration (p < 0.05) and the annual risk of ONJ was judged to be the least important attribute. CONCLUSIONS: When making treatment decisions regarding the choice of BTA, delaying the onset of SREs/worsening of pain and reducing the risk of renal impairment are the primary objectives for physicians. More... »

PAGES

518

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12913-018-3272-x

DOI

http://dx.doi.org/10.1186/s12913-018-3272-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1105291556

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29970078


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Amgen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Health Economics, Amgen Inc, 91320, Thousand Oaks, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Qian", 
        "givenName": "Yi", 
        "id": "sg:person.0704001220.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704001220.62"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amgen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Health Economics, Amgen Inc, 91320, Thousand Oaks, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Arellano", 
        "givenName": "Jorge", 
        "id": "sg:person.0703211000.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703211000.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amgen (Switzerland)", 
          "id": "https://www.grid.ac/institutes/grid.476152.3", 
          "name": [
            "Health Economics, Amgen (Europe) GmbH, Zug, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gatta", 
        "givenName": "Francesca", 
        "id": "sg:person.01065552600.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01065552600.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amgen (Switzerland)", 
          "id": "https://www.grid.ac/institutes/grid.476152.3", 
          "name": [
            "Health Economics, Amgen (Europe) GmbH, Zug, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hechmati", 
        "givenName": "Guy", 
        "id": "sg:person.01211131524.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211131524.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "RTI International", 
          "id": "https://www.grid.ac/institutes/grid.62562.35", 
          "name": [
            "RTI Health Solutions, Research Triangle Park, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hauber", 
        "givenName": "A. Brett", 
        "id": "sg:person.01056511624.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01056511624.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "RTI International", 
          "id": "https://www.grid.ac/institutes/grid.62562.35", 
          "name": [
            "RTI Health Solutions, Research Triangle Park, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mohamed", 
        "givenName": "Ateesha F.", 
        "id": "sg:person.0712660463.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0712660463.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Bristol Royal Infirmary", 
          "id": "https://www.grid.ac/institutes/grid.418482.3", 
          "name": [
            "Bristol Haematology and Oncology Centre, University Hospitals Bristol, Bristol Royal Infirmary, Avon, Bristol, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bahl", 
        "givenName": "Amit", 
        "id": "sg:person.01016070212.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016070212.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Kantonsspital Graub\u00fcnden", 
          "id": "https://www.grid.ac/institutes/grid.452286.f", 
          "name": [
            "Department of Oncology/Hematology, Kantonsspital Graub\u00fcnden, Chur, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "von Moos", 
        "givenName": "Roger", 
        "id": "sg:person.01075054376.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01075054376.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Medicine, CHU Brugmann, ULB, Brussels, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Body", 
        "givenName": "Jean-Jacques", 
        "id": "sg:person.01311556701.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01311556701.37"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1136/ejhpharm-2012-000235", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002694461"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00520-006-0166-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003674970", 
          "https://doi.org/10.1007/s00520-006-0166-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00520-006-0166-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003674970", 
          "https://doi.org/10.1007/s00520-006-0166-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.lungcan.2009.08.020", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003677722"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00520-013-2022-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008707820", 
          "https://doi.org/10.1007/s00520-013-2022-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jval.2014.10.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009988746"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/11593370-000000000-00000", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010605261", 
          "https://doi.org/10.2165/11593370-000000000-00000"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/1-4020-3684-1_7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015379515", 
          "https://doi.org/10.1007/1-4020-3684-1_7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.clon.2005.06.016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016855246"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(10)62344-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020911264"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/djh141", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022702187"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.20308", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023272442"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2012.08.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023695371"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/(sici)1097-0142(20000301)88:5<1082::aid-cncr20>3.0.co;2-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024382052"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00402-001-0359-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027765642", 
          "https://doi.org/10.1007/s00402-001-0359-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-06-0931", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027987816"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00520-013-1932-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029977786", 
          "https://doi.org/10.1007/s00520-013-1932-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.joms.2005.07.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030354482"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3747/co.19.1011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030497291"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jval.2010.11.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030781921"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/tcrm.s2707", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031092761"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3111/13696998.2013.774279", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032942190"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2796.1999.00507.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034358174"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(97)10128-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036064494"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00520-013-1755-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036639042", 
          "https://doi.org/10.1007/s00520-013-1755-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3111/13696998.2013.779921", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036786358"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/11539650-000000000-00000", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039139143", 
          "https://doi.org/10.2165/11539650-000000000-00000"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/11539650-000000000-00000", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039139143", 
          "https://doi.org/10.2165/11539650-000000000-00000"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(99)00331-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040374898"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2010.29.7101", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041239357"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdr435", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044392240"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1213755", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046224838"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1023/a:1012506426440", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056305893"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2307/3172883", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070217220"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3747/co.22.2380", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071359541"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1017/cbo9780511753831", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1098665042"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1017/cbo9780511610356", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1098712532"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1017/cbo9780511753930", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1098721478"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-12", 
    "datePublishedReg": "2018-12-01", 
    "description": "BACKGROUND: Several bone-targeted agents (BTAs) are available for preventing skeletal-related events (SREs), but they vary in terms of efficacy, safety and mode of administration. This study assessed data on European physicians' treatment preferences for preventing SREs in patients with bone metastases from solid tumours.\nMETHODS: Physicians completed a web-based discrete-choice experiment survey of 10 choices between pairs of profiles of hypothetical BTAs for a putative patient. Each profile included five attributes within a pre-defined range (primarily based on existing BTAs' prescribing information): time (months) until the first SRE; time (months) until worsening of pain; annual risk of osteonecrosis of the jaw (ONJ); annual risk of renal impairment; and mode of administration. Choice questions were developed using an experimental design with known statistical properties. A separate main-effects random parameters logit model was estimated for each country and provided the relative preference for the treatment attributes in the study.\nRESULTS: A total of 191 physicians in France, 192 physicians in Germany, and 197 physicians in the United Kingdom completed the survey. In France and the United Kingdom, time until the first SRE and risk of renal impairment were the most important attributes; in Germany, time until the first SRE and delay in worsening of pain were the most important. In all countries, a 120-min infusion every 4\u00a0weeks was the least preferred mode of administration (p\u2009<\u20090.05) and the annual risk of ONJ was judged to be the least important attribute.\nCONCLUSIONS: When making treatment decisions regarding the choice of BTA, delaying the onset of SREs/worsening of pain and reducing the risk of renal impairment are the primary objectives for physicians.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12913-018-3272-x", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1327417", 
        "issn": [
          "1472-6963"
        ], 
        "name": "BMC Health Services Research", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "18"
      }
    ], 
    "name": "Physicians\u2019 preferences for bone metastases treatments in France, Germany and the United Kingdom", 
    "pagination": "518", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "3d06fd8ab8dc1d4e9b52678ab5490b3cbf3f8551a9fd25259ceb9cc4e9ab17f7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29970078"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101088677"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12913-018-3272-x"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1105291556"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12913-018-3272-x", 
      "https://app.dimensions.ai/details/publication/pub.1105291556"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T23:34", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8693_00000571.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs12913-018-3272-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12913-018-3272-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12913-018-3272-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12913-018-3272-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12913-018-3272-x'


 

This table displays all metadata directly associated to this object as RDF triples.

254 TRIPLES      21 PREDICATES      65 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12913-018-3272-x schema:about anzsrc-for:11
2 anzsrc-for:1117
3 schema:author Nfef23b28726740b091b8158c10a614d7
4 schema:citation sg:pub.10.1007/1-4020-3684-1_7
5 sg:pub.10.1007/s00402-001-0359-2
6 sg:pub.10.1007/s00520-006-0166-y
7 sg:pub.10.1007/s00520-013-1755-1
8 sg:pub.10.1007/s00520-013-1932-2
9 sg:pub.10.1007/s00520-013-2022-1
10 sg:pub.10.2165/11539650-000000000-00000
11 sg:pub.10.2165/11593370-000000000-00000
12 https://doi.org/10.1002/(sici)1097-0142(20000301)88:5<1082::aid-cncr20>3.0.co;2-z
13 https://doi.org/10.1002/cncr.20308
14 https://doi.org/10.1016/j.clon.2005.06.016
15 https://doi.org/10.1016/j.ejca.2012.08.002
16 https://doi.org/10.1016/j.joms.2005.07.010
17 https://doi.org/10.1016/j.jval.2010.11.013
18 https://doi.org/10.1016/j.jval.2014.10.004
19 https://doi.org/10.1016/j.lungcan.2009.08.020
20 https://doi.org/10.1016/s0140-6736(10)62344-6
21 https://doi.org/10.1016/s0959-8049(97)10128-9
22 https://doi.org/10.1016/s0959-8049(99)00331-7
23 https://doi.org/10.1017/cbo9780511610356
24 https://doi.org/10.1017/cbo9780511753831
25 https://doi.org/10.1017/cbo9780511753930
26 https://doi.org/10.1023/a:1012506426440
27 https://doi.org/10.1046/j.1365-2796.1999.00507.x
28 https://doi.org/10.1056/nejmoa1213755
29 https://doi.org/10.1093/annonc/mdr435
30 https://doi.org/10.1093/jnci/djh141
31 https://doi.org/10.1136/ejhpharm-2012-000235
32 https://doi.org/10.1158/1078-0432.ccr-06-0931
33 https://doi.org/10.1200/jco.2010.29.7101
34 https://doi.org/10.2147/tcrm.s2707
35 https://doi.org/10.2307/3172883
36 https://doi.org/10.3111/13696998.2013.774279
37 https://doi.org/10.3111/13696998.2013.779921
38 https://doi.org/10.3747/co.19.1011
39 https://doi.org/10.3747/co.22.2380
40 schema:datePublished 2018-12
41 schema:datePublishedReg 2018-12-01
42 schema:description BACKGROUND: Several bone-targeted agents (BTAs) are available for preventing skeletal-related events (SREs), but they vary in terms of efficacy, safety and mode of administration. This study assessed data on European physicians' treatment preferences for preventing SREs in patients with bone metastases from solid tumours. METHODS: Physicians completed a web-based discrete-choice experiment survey of 10 choices between pairs of profiles of hypothetical BTAs for a putative patient. Each profile included five attributes within a pre-defined range (primarily based on existing BTAs' prescribing information): time (months) until the first SRE; time (months) until worsening of pain; annual risk of osteonecrosis of the jaw (ONJ); annual risk of renal impairment; and mode of administration. Choice questions were developed using an experimental design with known statistical properties. A separate main-effects random parameters logit model was estimated for each country and provided the relative preference for the treatment attributes in the study. RESULTS: A total of 191 physicians in France, 192 physicians in Germany, and 197 physicians in the United Kingdom completed the survey. In France and the United Kingdom, time until the first SRE and risk of renal impairment were the most important attributes; in Germany, time until the first SRE and delay in worsening of pain were the most important. In all countries, a 120-min infusion every 4 weeks was the least preferred mode of administration (p < 0.05) and the annual risk of ONJ was judged to be the least important attribute. CONCLUSIONS: When making treatment decisions regarding the choice of BTA, delaying the onset of SREs/worsening of pain and reducing the risk of renal impairment are the primary objectives for physicians.
43 schema:genre research_article
44 schema:inLanguage en
45 schema:isAccessibleForFree true
46 schema:isPartOf N98d64c8f40ed4fa6b12cb45cf6b37c63
47 Nbe91a1cd8b904d90a7027940c61c1696
48 sg:journal.1327417
49 schema:name Physicians’ preferences for bone metastases treatments in France, Germany and the United Kingdom
50 schema:pagination 518
51 schema:productId N4dc123f898e5478ab44648706a452e2f
52 N80db4712264e468a8dd0648c401c69cb
53 Na7b0f73177a943d9bf631b111644832e
54 Nacbf715aed8b42a7af3e51fe934b17c9
55 Nce70285c8b364c7aa07a94fba721ad44
56 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105291556
57 https://doi.org/10.1186/s12913-018-3272-x
58 schema:sdDatePublished 2019-04-10T23:34
59 schema:sdLicense https://scigraph.springernature.com/explorer/license/
60 schema:sdPublisher N9849831a8c5a4cda9aec95dd06120c15
61 schema:url https://link.springer.com/10.1186%2Fs12913-018-3272-x
62 sgo:license sg:explorer/license/
63 sgo:sdDataset articles
64 rdf:type schema:ScholarlyArticle
65 N4dc123f898e5478ab44648706a452e2f schema:name readcube_id
66 schema:value 3d06fd8ab8dc1d4e9b52678ab5490b3cbf3f8551a9fd25259ceb9cc4e9ab17f7
67 rdf:type schema:PropertyValue
68 N4fd238dc98da4670abde19154349826d rdf:first sg:person.01211131524.31
69 rdf:rest Nce2eba7d4acf463097d5b23e17ee9402
70 N55faa1bba61148239d5f411abc1182e7 rdf:first sg:person.0712660463.63
71 rdf:rest N89de460aaa0d4bc385b86dbb843dcd21
72 N6f54c7ea62d3440b9e32dd7a4dd30709 rdf:first sg:person.01075054376.08
73 rdf:rest Nf29d1e8e7163486aa30919edf523921b
74 N80db4712264e468a8dd0648c401c69cb schema:name nlm_unique_id
75 schema:value 101088677
76 rdf:type schema:PropertyValue
77 N89de460aaa0d4bc385b86dbb843dcd21 rdf:first sg:person.01016070212.40
78 rdf:rest N6f54c7ea62d3440b9e32dd7a4dd30709
79 N9849831a8c5a4cda9aec95dd06120c15 schema:name Springer Nature - SN SciGraph project
80 rdf:type schema:Organization
81 N98d64c8f40ed4fa6b12cb45cf6b37c63 schema:issueNumber 1
82 rdf:type schema:PublicationIssue
83 Na7b0f73177a943d9bf631b111644832e schema:name pubmed_id
84 schema:value 29970078
85 rdf:type schema:PropertyValue
86 Nacbf715aed8b42a7af3e51fe934b17c9 schema:name dimensions_id
87 schema:value pub.1105291556
88 rdf:type schema:PropertyValue
89 Nb0bc8806b1b34644a58abbd999f19614 rdf:first sg:person.01065552600.97
90 rdf:rest N4fd238dc98da4670abde19154349826d
91 Nbe91a1cd8b904d90a7027940c61c1696 schema:volumeNumber 18
92 rdf:type schema:PublicationVolume
93 Nce2eba7d4acf463097d5b23e17ee9402 rdf:first sg:person.01056511624.10
94 rdf:rest N55faa1bba61148239d5f411abc1182e7
95 Nce70285c8b364c7aa07a94fba721ad44 schema:name doi
96 schema:value 10.1186/s12913-018-3272-x
97 rdf:type schema:PropertyValue
98 Nef692a40a41949a5b4376b748ce51ae2 rdf:first sg:person.0703211000.91
99 rdf:rest Nb0bc8806b1b34644a58abbd999f19614
100 Nf29d1e8e7163486aa30919edf523921b rdf:first sg:person.01311556701.37
101 rdf:rest rdf:nil
102 Nfaa9ff9b72b34c229f29f9a48ec5957e schema:name Department of Medicine, CHU Brugmann, ULB, Brussels, Belgium
103 rdf:type schema:Organization
104 Nfef23b28726740b091b8158c10a614d7 rdf:first sg:person.0704001220.62
105 rdf:rest Nef692a40a41949a5b4376b748ce51ae2
106 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
107 schema:name Medical and Health Sciences
108 rdf:type schema:DefinedTerm
109 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
110 schema:name Public Health and Health Services
111 rdf:type schema:DefinedTerm
112 sg:journal.1327417 schema:issn 1472-6963
113 schema:name BMC Health Services Research
114 rdf:type schema:Periodical
115 sg:person.01016070212.40 schema:affiliation https://www.grid.ac/institutes/grid.418482.3
116 schema:familyName Bahl
117 schema:givenName Amit
118 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016070212.40
119 rdf:type schema:Person
120 sg:person.01056511624.10 schema:affiliation https://www.grid.ac/institutes/grid.62562.35
121 schema:familyName Hauber
122 schema:givenName A. Brett
123 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01056511624.10
124 rdf:type schema:Person
125 sg:person.01065552600.97 schema:affiliation https://www.grid.ac/institutes/grid.476152.3
126 schema:familyName Gatta
127 schema:givenName Francesca
128 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01065552600.97
129 rdf:type schema:Person
130 sg:person.01075054376.08 schema:affiliation https://www.grid.ac/institutes/grid.452286.f
131 schema:familyName von Moos
132 schema:givenName Roger
133 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01075054376.08
134 rdf:type schema:Person
135 sg:person.01211131524.31 schema:affiliation https://www.grid.ac/institutes/grid.476152.3
136 schema:familyName Hechmati
137 schema:givenName Guy
138 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211131524.31
139 rdf:type schema:Person
140 sg:person.01311556701.37 schema:affiliation Nfaa9ff9b72b34c229f29f9a48ec5957e
141 schema:familyName Body
142 schema:givenName Jean-Jacques
143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01311556701.37
144 rdf:type schema:Person
145 sg:person.0703211000.91 schema:affiliation https://www.grid.ac/institutes/grid.417886.4
146 schema:familyName Arellano
147 schema:givenName Jorge
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703211000.91
149 rdf:type schema:Person
150 sg:person.0704001220.62 schema:affiliation https://www.grid.ac/institutes/grid.417886.4
151 schema:familyName Qian
152 schema:givenName Yi
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704001220.62
154 rdf:type schema:Person
155 sg:person.0712660463.63 schema:affiliation https://www.grid.ac/institutes/grid.62562.35
156 schema:familyName Mohamed
157 schema:givenName Ateesha F.
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0712660463.63
159 rdf:type schema:Person
160 sg:pub.10.1007/1-4020-3684-1_7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015379515
161 https://doi.org/10.1007/1-4020-3684-1_7
162 rdf:type schema:CreativeWork
163 sg:pub.10.1007/s00402-001-0359-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027765642
164 https://doi.org/10.1007/s00402-001-0359-2
165 rdf:type schema:CreativeWork
166 sg:pub.10.1007/s00520-006-0166-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1003674970
167 https://doi.org/10.1007/s00520-006-0166-y
168 rdf:type schema:CreativeWork
169 sg:pub.10.1007/s00520-013-1755-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036639042
170 https://doi.org/10.1007/s00520-013-1755-1
171 rdf:type schema:CreativeWork
172 sg:pub.10.1007/s00520-013-1932-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029977786
173 https://doi.org/10.1007/s00520-013-1932-2
174 rdf:type schema:CreativeWork
175 sg:pub.10.1007/s00520-013-2022-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008707820
176 https://doi.org/10.1007/s00520-013-2022-1
177 rdf:type schema:CreativeWork
178 sg:pub.10.2165/11539650-000000000-00000 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039139143
179 https://doi.org/10.2165/11539650-000000000-00000
180 rdf:type schema:CreativeWork
181 sg:pub.10.2165/11593370-000000000-00000 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010605261
182 https://doi.org/10.2165/11593370-000000000-00000
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1002/(sici)1097-0142(20000301)88:5<1082::aid-cncr20>3.0.co;2-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1024382052
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1002/cncr.20308 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023272442
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1016/j.clon.2005.06.016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016855246
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1016/j.ejca.2012.08.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023695371
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1016/j.joms.2005.07.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030354482
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1016/j.jval.2010.11.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030781921
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1016/j.jval.2014.10.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009988746
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1016/j.lungcan.2009.08.020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003677722
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1016/s0140-6736(10)62344-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020911264
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1016/s0959-8049(97)10128-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036064494
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1016/s0959-8049(99)00331-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040374898
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1017/cbo9780511610356 schema:sameAs https://app.dimensions.ai/details/publication/pub.1098712532
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1017/cbo9780511753831 schema:sameAs https://app.dimensions.ai/details/publication/pub.1098665042
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1017/cbo9780511753930 schema:sameAs https://app.dimensions.ai/details/publication/pub.1098721478
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1023/a:1012506426440 schema:sameAs https://app.dimensions.ai/details/publication/pub.1056305893
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1046/j.1365-2796.1999.00507.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1034358174
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1056/nejmoa1213755 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046224838
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1093/annonc/mdr435 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044392240
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1093/jnci/djh141 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022702187
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1136/ejhpharm-2012-000235 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002694461
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1158/1078-0432.ccr-06-0931 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027987816
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1200/jco.2010.29.7101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041239357
227 rdf:type schema:CreativeWork
228 https://doi.org/10.2147/tcrm.s2707 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031092761
229 rdf:type schema:CreativeWork
230 https://doi.org/10.2307/3172883 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070217220
231 rdf:type schema:CreativeWork
232 https://doi.org/10.3111/13696998.2013.774279 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032942190
233 rdf:type schema:CreativeWork
234 https://doi.org/10.3111/13696998.2013.779921 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036786358
235 rdf:type schema:CreativeWork
236 https://doi.org/10.3747/co.19.1011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030497291
237 rdf:type schema:CreativeWork
238 https://doi.org/10.3747/co.22.2380 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071359541
239 rdf:type schema:CreativeWork
240 https://www.grid.ac/institutes/grid.417886.4 schema:alternateName Amgen (United States)
241 schema:name Health Economics, Amgen Inc, 91320, Thousand Oaks, CA, USA
242 rdf:type schema:Organization
243 https://www.grid.ac/institutes/grid.418482.3 schema:alternateName Bristol Royal Infirmary
244 schema:name Bristol Haematology and Oncology Centre, University Hospitals Bristol, Bristol Royal Infirmary, Avon, Bristol, UK
245 rdf:type schema:Organization
246 https://www.grid.ac/institutes/grid.452286.f schema:alternateName Kantonsspital Graubünden
247 schema:name Department of Oncology/Hematology, Kantonsspital Graubünden, Chur, Switzerland
248 rdf:type schema:Organization
249 https://www.grid.ac/institutes/grid.476152.3 schema:alternateName Amgen (Switzerland)
250 schema:name Health Economics, Amgen (Europe) GmbH, Zug, Switzerland
251 rdf:type schema:Organization
252 https://www.grid.ac/institutes/grid.62562.35 schema:alternateName RTI International
253 schema:name RTI Health Solutions, Research Triangle Park, NC, USA
254 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...